COVID-19 Booster Study In Immunocompromised Patients Gives Novavax Another Shot On Goal

Manufacturing Issues Have Delayed Filing

 
• By Andrew McConaghie
  
Novavax
Novavax has seen its regulatory filings delayed by manufacturing supply and quality issues, but finally looks set to gain its first authorizations later this year.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip